Immune-related adverse events to predict outcomes in recurrent/metastatic cervical cancer treated with cemiplimab: Insights from a rescue access program in Poland.

Authors: Renata Pacholczak-Madej, Maja Lisik-Habib, Radoslaw Madry, Monika Szarszewska, Zuzanna Borysiewicz, Katarzyna Gabalewicz, Ewa Iwańska, Wiktor Szatkowski, Miroslawa Puskulluoglu, Pawel Blecharz

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e17504

Source: Full article

---

Abstract

e17504